SASusan W. Aucott

Susan W. Aucott

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Susan W. Aucott has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • P K Donohue

    Division of Neonatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    2 shared publications
  • A H Streubel

    Division of Neonatology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21287-3200, USA

    1 shared publication
  • K L Watterberg

    Division of Neonatology, Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, NM, USA

    1 shared publication
  • Kristi L. Watterberg

    Department of Pediatrics, School of Medicine, University of New Mexico, Albuquerque, New Mexico

    1 shared publication
  • M L Shaffer

    Department of Public Health Sciences and Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA, USA

    1 shared publication
  • Michele L. Shaffer

    Department of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania

    1 shared publication

Latest Publications

  • Open Access

    Early cortisol values and long-term outcomes in extremely low birth weight infants

    by S W Aucott, K L Watterberg, M L Shaffer, P K Donohue, for the PROPHET study group

    Objective: Both excess and insufficient levels of glucocorticoid in extremely low birth weight (ELBW) infants have been associated with adverse hospital outcomes, whereas excess glucocorticoid exposure has been associated with long-term adverse neurodevelopment. Our objective was to evaluate the relationship between neonatal cortisol concentrations and long-term outcomes of growth and neurodevelopment. Study Design: As part of a multicenter randomized trial of hydrocortisone treatment for prophylaxis of relative adrenal insufficiency, cortisol concentrations were obtained at 12 to 48 h of postnatal age and at days 5 to 7 on 350 intubated ELBW infants, of whom 252 survived and returned for neurodevelopmental follow-up at 18 to 22 months corrected age. Cortisol values from each time point were divided into quartiles. Growth and neurodevelopmental outcome were compared for each quartile. Result: Median cortisol value was 16.0 μg per 100 ml at baseline for all infants, and 13.1 μg per 100 ml on days 5 to 7 in the placebo group. Outcomes did not differ in each quartile between treatment and placebo groups. Low cortisol values at baseline or at days 5 to 7 were not associated with impaired growth or neurodevelopment at 18 to 22 months corrected age. High cortisol values were associated with an increase in cerebral palsy, related to the increased incidence of severe intraventricular hemorrhage (IVH) and periventricular leukomalacia. Conclusion: Low cortisol concentrations were not predictive of adverse long-term outcomes. High cortisol concentrations, although predictive of short-term adverse outcomes such as IVH and periventricular leukomalacia, did not additionally predict adverse outcome. Further analysis into identifying factors that modulate cortisol concentrations shortly after birth could improve our ability to identify those infants who are most likely to benefit from treatment with hydrocortisone.


  • Do Cortisol Concentrations Predict Short-Term Outcomes in Extremely Low Birth Weight Infants?

    by Susan W. Aucott, Kristi L. Watterberg, Michele L. Shaffer, Pamela K. Donohue, for the PROPHET Study Group

    OBJECTIVE. Relative adrenal insufficiency in extremely low birth weight infants may contribute to significant morbidity and death. Our objective was to evaluate the relationship between cortisol concentrations and short-term outcomes.METHODS. Cortisol concentrations were obtained for 350 intubated, extremely low birth weight infants at postnatal age of 12 to 48 hours and at day 5 to 7, as part of a multicenter, randomized trial of hydrocortisone treatment for prophylaxis of relative adrenal insufficiency. Death and short-term morbidity were monitored prospectively. Cortisol levels at each time point were divided into quartiles. The incidence rates of outcomes were determined for each quartile and for infants with cortisol values of 90th percentile.RESULTS. Median cortisol values were 16.0 μg/dL at baseline and 13.1 μg/dL on day 5 to 7 in the placebo group. Outcomes did not differ in each quartile between treatment and placebo groups. Low cortisol values at baseline or day 5 to 7 were not associated with increased morbidity or mortality rates and were not predictive of open-label hydrocortisone use. In fact, vasopressor use was lower for infants with lower cortisol values at baseline. Severe intraventricular hemorrhage was more frequent in infants with cortisol levels in the upper quartile at baseline, and values of >90th percentile were significantly associated with higher rates of death, severe intraventricular hemorrhage, periventricular leukomalacia, gastrointestinal perforation, and severe retinopathy of prematurity.CONCLUSIONS. Low cortisol concentrations were not predictive of adverse short-term outcomes, but high cortisol concentrations were associated with severe intraventricular hemorrhage, and extremely elevated values were associated with morbidity and death. Low cortisol concentrations alone at these 2 time points did not identify the infants at highest risk for adverse outcomes. In contrast, high cortisol values were associated with increased morbidity and mortality rates.


  • The epidemiology of atypical chronic lung disease in extremely low birth weight infants

    by A H Streubel, P K Donohue, S W Aucott

    Objective: Study Design: Result: Conclusion: